文献速递骨肌技术与安全CTMR

多发性骨髓瘤纵轴骨受累纵向监测中定性及定量CT与MRI参数的比较

Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.
PubMed 文献 · Skeletal Radiol · 2017-12-08

纳入31例多发性骨髓瘤患者的47次随访,比较多参数非增强全身MRI与非增强全身低剂量薄层CT的定性与定量参数用于纵向疾病监测,以血液学M梯度为标准,结果显示仅在使用定性参数时MRI反应监测优于CT,定量参数在CT或MRI均未显示明确获益。

要点

  • 定性MRI评估反应优于定性CT,但定量参数在CT或MRI均无明确额外获益。
  • CT无法可靠区分部分缓解与完全缓解,故将SD/PR/VGPR/CR合并分析。
  • 弥漫性骨髓受累者达SD/PR/VGPR/CR时,STIR序列信号强度显著下降。

核心结论

  • 仅在使用定性参数时,MRI反应监测优于CT;定量参数在CT或MRI均未显示明确获益。

研究设计与样本

  • 研究类型为纵向比较研究,纳入31例连续多发性骨髓瘤患者(17例男性,平均年龄59.20±8.08岁),2013年6月至2016年9月间接受基线及至少一次随访检查,共47次随访。
  • 检查方法为多参数非增强全身MRI(WBMRI)与非增强全身低剂量薄层MDCT(NEWBMDCT),参考标准为血液学实验室M梯度。

关键影像表现/征象

  • 定性CT评估显示进展12/47例(25.5%),稳定/部分缓解/非常好的部分缓解/完全缓解共35/47例(74.5%)。
  • 定量CT在所有局灶性溶骨性病变中证实了上述结果(p<0.001);弥漫性骨受累部位达稳定/部分缓解/非常好的部分缓解/完全缓解组最大骨衰减值显著增高(p<0.001),最小骨衰减值显著降低(p<0.002)。
  • 定性MRI显示进展14/47例(29.7%),稳定/部分缓解/非常好的部分缓解/完全缓解共33/47例(70.3%);弥漫性骨髓受累且达稳定/部分缓解/非常好的部分缓解/完全缓解者,短tau反转恢复序列(STIR)骨髓信号强度显著下降(p<0.001)。

诊断标准与关键数值

  • 血液学反应分类:完全缓解14/47例(29.7%),部分缓解2/47例(4.2%),稳定16/47例(34.0%),进展15/47例(29.9%)。
  • 定性CT反应标准分为进展、稳定、部分缓解/非常好的部分缓解和完全缓解,因CT无法可靠评估部分缓解与完全缓解,统计分析时将后三者合并。
  • 定性MR反应标准参照CT类似分组,采用T1w/STIR/T2*w信号强度变化的纵向定量及ADC值计算。

临床应用与阅片要点

  • 定性MRI参数可用于多发性骨髓瘤纵轴骨受累的纵向反应监测,定性CT需注意其无法可靠区分部分缓解与完全缓解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare qualitative and quantitative computed tomography (CT) and magnetic resonance imaging (MRI) parameters for longitudinal disease monitoring of multiple myeloma (MM) of the axial skeleton.

MATERIALS AND METHODS: We included 31 consecutive patients (17 m; mean age 59.20 ± 8.08 years) with MM, who underwent all baseline (n = 31) and at least one or more (n = 47) follow-up examinations consisting of multi-parametric non-enhanced whole-body MRI (WBMRI) and non-enhanced whole-body reduced-dose thin-section MDCT (NEWBMDCT) between 06/2013 and 09/2016. We classified response according to qualitative CT criteria into progression (PD), stable(SD), partial/very good partial (PR/VGPR) and complete response(CR), grouping the latter three together for statistical analysis because CT cannot reliably assess PR and CR. Qualitative MR-response criteria were defined and grouped similarly to CT using longitudinal quantification of signal-intensity changes on T1w/STIR/ T2*w and calculating ADC-values. Standard of reference was the hematological laboratory (M-gradient).

RESULTS: Hematological response categories were CR (14/47, 29.7%), PR (2/47, 4.2%), SD (16/47, 34.0%) and PD (15/47, 29.9%). Qualitative-CT-evaluation showed PD in 12/47 (25.5%) and SD/PR/VGPR/CR in 35/47 (74.5%) cases. These results were confirmed by quantitative-CT in all focal lytic lesions (p < 0.001). Quantitative-CT at sites with diffuse bone involvement showed significant increase of maximum bone attenuation (p < 0.001*) and significant decrease of minimal bone (p < 0.002*) in the SD/PR/VGPR/CR group. Qualitative MRI showed PD in 14/47 (29.7%) and SD/PR/VGPR/CR in 33/47 (70.3%). Quantitative MRI diagnosis showed a statistically significant decrease in signal intensity on short tau inversion recovery sequences (STIR) in bone marrow in patients with diffuse bone marrow involvement achieving SD/PR/VGPR/CR (p < 0.001*).

CONCLUSION: Imaging response monitoring using MRI is superior to CT only if qualitative parameters are used, whereas there was no definite benefit from using quantitative parameters with either CT or MRI.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Horger M, Fritz J, Thaiss WM, et al. Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma. Skeletal Radiol. 2017. PMID: 29222688. doi:10.1007/s00256-017-2827-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。